Artwork

ASCO 2025 Plenary - MATTERHORN

Two Onc Docs

11 subscribers

published

iconShare
 
Manage episode 493057143 series 3421368
Content provided by Sam and Karine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam and Karine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA.

  continue reading

156 episodes